Analgesics - Malaysia | Statista Market Forecast

In Malaysia, the revenue generated in the Analgesics market in 2024 amounts to MYR US$140.30m.
It is projected that the market will experience an annual growth rate of 8.13% (CAGR 2024-2029).
When compared to other countries worldwide, the United States leads in terms of revenue, generating a staggering US$7.24bn in 2024.
In relation to the total population of Malaysia, the per person revenue in the Analgesics market is MYR US$4.05 in 2024.
Malaysia's analgesics market is witnessing a surge in demand for traditional herbal remedies as consumers seek natural alternatives.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Malaysia is experiencing steady growth due to various factors.

Customer preferences: Customers in Malaysia have shown a growing preference for analgesics as a means to alleviate pain and discomfort. This is primarily driven by the increasing awareness about the benefits of analgesics in managing pain and the convenience they offer in providing quick relief. Additionally, the aging population in Malaysia has contributed to the rising demand for analgesics, as older individuals often experience chronic pain and require regular pain management.

Trends in the market: One of the key trends in the Analgesics market in Malaysia is the growing popularity of over-the-counter (OTC) analgesics. OTC analgesics are easily accessible and do not require a prescription, making them a convenient option for consumers. This trend is driven by the increasing self-medication practices among Malaysians, as they prefer to manage their pain independently without visiting a healthcare professional. Furthermore, the availability of a wide range of OTC analgesics in various forms such as tablets, creams, and sprays has also contributed to their growing popularity. Another trend in the market is the rising demand for natural and herbal analgesics. Consumers in Malaysia are becoming more conscious about the ingredients used in analgesics and are opting for products that are perceived to be more natural and less chemically-based. This trend is in line with the global shift towards natural and organic products, as consumers are increasingly seeking alternatives to traditional pharmaceuticals.

Local special circumstances: One of the unique aspects of the Analgesics market in Malaysia is the strong influence of traditional medicine practices. Malaysians have a long-standing tradition of using herbal remedies for pain relief, and this has influenced their preferences in the analgesics market. Many consumers in Malaysia still rely on traditional remedies such as herbal oils and balms for pain management. This has created a niche market for traditional analgesics, which cater to those who prefer natural and traditional remedies over conventional pharmaceuticals.

Underlying macroeconomic factors: The growing economy and increasing disposable income in Malaysia have also contributed to the growth of the Analgesics market. As people have more purchasing power, they are able to afford analgesics and are willing to spend on products that improve their quality of life. Additionally, the expanding healthcare infrastructure and access to healthcare services in Malaysia have made it easier for consumers to seek medical advice and obtain analgesics when needed. In conclusion, the Analgesics market in Malaysia is witnessing growth due to customer preferences for quick pain relief, the popularity of OTC analgesics, the demand for natural and herbal products, the influence of traditional medicine practices, and the underlying macroeconomic factors such as a growing economy and increasing disposable income.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.